#China #Guangzhou #AI Solutions #Fangzhou Inc. #Healthcare Apps

Fangzhou Inc. Ranks First in China's Healthcare App Store

Fangzhou Inc., renowned for its pioneering online healthcare solutions, has recently clinched the top position in the Healthcare category of China's App Store. This news, reported on July 3, 2025, reveals Fangzhou's outstanding performance in the App Store's TOP100 Free Apps for June 2025, an impressive jump of nine places from the previous month. This accomplishment underscores the rising popularity and adoption of Fangzhou's innovative healthcare offerings, particularly its AI-driven online pharmacy application.

Since its inception, Fangzhou has significantly shaped the landscape of internet healthcare in China. Notably, their online pharmacy platform has consistently emerged as the most active vertical healthcare platform in the country, sustaining its dominance since 2020. As of December 31, 2024, Fangzhou recorded 49.2 million registered users, a notable increase from 42.7 million in 2023, along with 10.1 million monthly active users—a 20% year-on-year growth. This surge is attributed to the continuous enhancements in chronic disease management services powered by artificial intelligence, leading to improved user engagement and satisfaction.

AI-Driven Healthcare Solutions

The company's CEO, Dr. Xie Fangmin, expressed pride in this achievement, emphasizing how it validates Fangzhou's AI-centric approach to healthcare services. He remarked, “Reaching this top ranking demonstrates our commitment to addressing the growing demand for convenient and reliable digital medical services in China.” He further affirmed that Fangzhou remains focused on technological innovations that align with the evolving healthcare requirements of its users.

Fangzhou's extensive digital supply chain now encompasses over 1,500 suppliers and 900 pharmaceutical corporations, including prominent multinational firms. This broad network allows the company to offer an expansive array of prescription medications, ensuring patients across China have access to essential health products.

Future Prospects with AI Innovation

Looking ahead, Fangzhou plans to intensify its focus on AI-driven innovations to enhance its service offerings. With its cutting-edge technological capabilities, the company aims to meet the mounting demand for personalized health services while contributing toward the goals set by the Healthy China 2030 initiative. Fangzhou is dedicated to integrating advanced AI technologies into its healthcare solutions that improve service quality, broaden access, and pioneer new digital health management models that resonate with national health priorities and patient needs.

As of December 31, 2024, Fangzhou is home to 223,000 physicians, affirming its position as a significant player in China's online chronic disease management sector. The company's strategic initiatives highlight its relentless dedication to transforming the patient experience through effective use of technology.

About Fangzhou Inc.

Fangzhou Inc. (06086.HK) stands at the forefront of online chronic disease management in China, serving millions of users with tailored medical care and precision medicine. The company's innovative approach not only meets immediate healthcare demands but also sets a foundation for future advancements in the sector. For additional information regarding Fangzhou and their initiatives, you can visit Fangzhou Investor Relations.

Conclusion

Fangzhou's ascent in the healthcare app rankings encapsulates a pivotal moment in China's digital health landscape. As technology continues to influence the way healthcare is delivered, Fangzhou is poised to remain at the cutting edge of this transformation, committed to enhancing healthcare accessibility and quality for millions of users across the nation.